CIK 0001444192 · Non-accelerated filer<br>Smaller reporting company
Grace Therapeutics, Inc.
Sign in to watch- Ticker
- GRCE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 609-322-1602
- Business address
- 103 CARNEGIE CENTER, SUITE 300, PRINCETON, NJ, 08540
- Former names
- Acasti Pharma Inc.
- Open-market buys, last 90 days
- $814,975
- in 11 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$814,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-17 | NEUGEBOREN EDWARD Director | Grant or award · Stock Option (Right to Buy) | +12,200 | 12,200 | ||
| 2026-09-17 | DAVIS A BRIAN Director | Grant or award · Stock Option (Right to Buy) | +0 | 12,200 | ||
| 2026-09-17 | Kavuru Vimal Director | Grant or award · Stock Option (Right to Buy) | +12,200 | 12,200 | ||
| 2026-09-17 | Kottayil George Director | Grant or award · Stock Option (Right to Buy) | +12,200 | 12,200 | ||
| 2026-09-09 | Opaleye Management Inc. 10% owner | Purchase | +5,836 | $2.09 | $12K | 2,775,229 |
| 2026-09-09 | Kohli Prashant Chief Executive Officer | Purchase | +100,000 | $2.14 | $214K | 121,357 |
| 2026-09-08 | Opaleye Management Inc. 10% owner | Purchase | +9,393 | $2.10 | $20K | 2,769,393 |
| 2026-08-28 | Kohli Prashant Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +267,160 | 267,160 | ||
| 2026-08-28 | Kumar Amresh VP Program Management | Grant or award · Stock Option (Right to Buy) | +35,760 | 35,760 | ||
| 2026-08-28 | Macdonald R. Loch Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +54,690 | 54,690 | ||
| 2026-08-28 | DelAversano Robert J Principal Financial Officer | Grant or award · Stock Option (Right to Buy) | +33,660 | 33,660 | ||
| 2026-08-14 | Opaleye Management Inc. 10% owner | Purchase | +11,608 | $2.09 | $24K | 2,760,000 |
| 2026-01-08 | Kavuru Vimal Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2026-01-08 | Kottayil George Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2026-01-08 | NEUGEBOREN EDWARD Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2026-01-08 | DAVIS A BRIAN Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-05-09 | Kottayil George Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-05-09 | NEUGEBOREN EDWARD Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-05-09 | DAVIS A BRIAN Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-05-09 | Kavuru Vimal Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 2 of 5 · 83 trades